Opinion on the development and research status of intelligent ophthalmology in China
10.3980/j.issn.1672-5123.2024.3.22
- VernacularTitle:中国智能眼科发展和研究现状之我见
- Author:
Di GONG
1
,
2
,
3
;
Wangting LI
1
,
2
,
3
;
Xiaomeng LI
1
,
2
,
3
;
Cheng WAN
1
,
2
,
3
;
Yongjin ZHOU
1
,
2
,
3
;
Yanwu XU
1
,
2
,
3
;
Shaochong ZHANG
1
,
2
,
3
;
Weihua YANG
1
,
2
,
3
Author Information
1. Shenzhen Eye Hospital
2. Shenzhen Eye Institute, Shenzhen 518040, Guangdong Province, China
3. Department of Ophthalmology, the First Affiliated Hospital of Jinan University, Guangzhou 510632, Guangdong Province, China
- Publication Type:Journal Article
- Keywords:
intelligent ophthalmology;
image analysis;
application standards;
academic exchange;
policy support
- From:
International Eye Science
2024;24(3):448-452
- CountryChina
- Language:Chinese
-
Abstract:
This paper provides a comprehensive analysis of the current state of intelligent ophthalmology in China, including technological advancements, academic exchange platforms, policy support, future challenges, and potential solutions. Technologically, remarkable progress have been made in various areas of intelligent ophthalmology in China, including diabetic retinopathy, fundus image analysis, and crucial aspects such as quality assessment of medical artificial intelligence products, clinical research methods, technological evaluation, and industrial standards. Researchers are constantly improving the safety and standardization of intelligent ophthalmology technology by formulating clinical application guidelines and standards. Academic exchange platforms have been established to provide extensive collaboration opportunities for professionals across diverse fields, and various academic journals serve as publication platforms for intelligent ophthalmology research. Regarding public policy, the Chinese government has not only established a supportive policy environment for the advancement of intelligent ophthalmology through various documents and regulations, but provided a legal basis and management framework. However, there are still challenges to overcome, such as technological innovation, data privacy and security, outdated regulations, and talent shortages. To tackle these issues, there is a requirement for increased technological research and development, the establishment of regulatory frameworks, talent cultivation, and greater awareness and acceptance of new technologies among patients. By comprehensively addressing these challenges, intelligent ophthalmology in China is expected to continue leading the industry's global development, bringing more innovation and convenience to the field of ophthalmic healthcare.
